Filter
34
Text search:
fluvoxamine
Featured
Recommendations
3
New Publications
3
Language
Document type
No document type
22
Guidelines
10
Manuals
2
Countries / Regions
Ethiopia
3
South Africa
2
Singapore
1
Latin America and the Carribbean
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
7
Clinical Guidelines
1
Key Resources
1
Toolboxes
Mental Health
23
COVID-19
6
Pharmacy
2
Conflict
1
AMR
1
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
MOH clinical practice guidelines
Updated Treatment Guidelines
Introduction
Chapter A.7
Anxiety disorders
Chapter F.2
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class
...
Abstract: Posttraumatic stress disorder (PTSD) is a chronic psychological disorder that can develop after exposure to a traumatic event. This review summarizes the literature on the epidemiology, assessment, and treatment of PTSD. We provide a review of the characteristics of PTSD along with associa
...
Anxiety disorders
Chapter F.3
Troubles Anxieux
Chapitre F.3
Edition en français
Traduction : Alexis Revet
Sous la direction de : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatment of these disorders
An Evidence-Based Treatment Guide for Clinicians
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up
...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
This book is a practical manual of mental health care for community health workers, primary care nurses, social workers and primary care doctors, particularly in developing countries.Helpful features include: over 50 illustrations and case studies, jargon-free explanations and descriptions, flow-cha
...
6th edition
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
